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“America’s Health First”: AMisnomer
Lawrence O. Gostin, JD
OnJuly 7, Tom Price, MD, secretaryof the Department of Health andHuman Se r v i ce s (HHS ) ,
announced the appointment of Brenda
Fitzgerald, MD, as the 17th director of the
Centers for Disease Control and Prevention
(CDC). To this position, Dr Fitzgerald brings
her experience as Commissioner of the
Georgia Department of Public Health, a role
in which she championed infant health and
survival, tobacco control, and obesity pre-
vention. Other significant choices of indi-
viduals to head agencies that affect the
public’shealth includetherecentnomination
of Jerome Adams, MD, MPH, as surgeon
general, and reappointment of Francis Col-
lins, MD, PhD, as National Institutes of
Health director.
While such choices appear to bode
well for public health, how well these
agencies and others will be funded for pro-
grams affecting public health both inside
and outside the United States matters
enormously. What has the Trump adminis-
tration signaled about its intentions in its
proposed budget?
Domestic Public Health
and Biomedicine
President Trump’s fiscal-year 2018 budget
contains sharp cuts to just about every-
thing in health and biomedicine—from
global health, state and local public health,
and grassroots community health through
to biomedical research. Importantly, the
budget calls for a 17% ($1.2 billion) reduc-
tion in funding for the nation’s public
health agency, the CDC, and its sister
office, the Agency for Toxic Substances
and Disease Registry, which investigates
environmental health hazards. Former
CDC Director Tom Frieden, MD, MPH,
characterized the proposed budget cut as
“the steepest in 20 years,” undermining
CDC’s ability to find, stop, and prevent
threats to US health.
Congress may well balk at steep cuts
to the nation’s capabilities for public
health and biomedicine. And while the
CDC has never been a politically favored
agency, the NIH maintains robust biparti-
san support in the Congress. What seems
crystal clear, however, is that the White
House views public health as discretionary
spending that is a source of budgetary sav-
ings, rather than as an essential public
good. President Trump similarly wants far
less resources devoted to international
development assistance for health.
Domestic public health preparedness is
more important now than ever, with a ris-
ing tide of opioid addiction, an ongoing
obesity epidemic, a steady drumbeat of
infectious and sexually transmitted dis-
eases (including HIV/AIDS), and the grow-
ing prospect of antimicrobial resistance.
Mental health services are woefully inad-
equate and need to be upgraded, not
scaled back. Just last summer, the United
States experienced a major scare (particu-
larly among women who are pregnant or of
childbearing age) as a Zika epidemic in Latin
America and the Caribbean (including
Puerto Rico) came to our shores. It could
happen again.
Among the most worrying proposed
budget cuts to the CDC include reductions
in funding for domestic HIV/AIDS ($186mil-
lion), chronic disease prevention and health
promotion ($222million), and public health
preparedness and response ($136 million),
mostly for emergency preparedness for
states and localities. This would hollow out
vital services to prevent and control the
nation’s major health threats.
The Senate Republicans’ collapsing
health care bill, the Better Care Reconcilia-
tion Act of 2017, would have inflicted still
deeper pain for the poor and middle class,
in the form of loss of health insurance cov-
erage for millions, immediate elimination of
the CDC’s Prevention and Public Health
Fund, severe cuts toMedicaid, and blocking
of Medicaid reimbursements to Planned
Parenthood. Overall, the bill would have
constituted a major step backwards in our
nation’s commitment to its people’s health.
And the White House’s deregulatory
agenda could do real harm to the fight
against obesity-related diseases. After sus-
tained lobbying from the packaged food
and beverage industry, the US Food and
DrugAdministration indefinitelydelayed the
launch of changes to Nutrition Facts labels
that were intended to help people eatmore
healthfully. The label changes, championed
by former first lady Michelle Obama, would
require adding information about “added
sugars” and highlighting calorie content in
large, bold text. The rollout of the new label
had been planned for July 2018 (with an
extension of 1 year for smaller companies).
The Trump administration also delayed
rules requiring calorie counts on restaurant
menus and future sodium reductions, while
loosening minimum requirements for
whole grain in school lunches.
Global Health Assistance
Beyond domestic public health prepared-
ness, the CDC has been the global leader in
fighting dangerous infectious diseases,
with transformative work on Ebola and Zika
outbreaks. Dr Frieden spearheaded an
agency focused on global health security,
with his signature initiative being the $1.1
billion Global Health Security Agenda
(GHSA). In fact, when Secretary Price
announced the appointment of Dr Fitzger-
ald to head the CDC, he referred to “work-
ing with Dr. Fitzgerald to achieve President
Trump’s goal of strengthening public health
surveillance and ensuring global health
security at home and abroad.” Yet, Presi-
dent Trump has proposed drastic cuts in
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global health assistance. The future of the
GHSA is verymuch in doubt.
Thesecuts flow fromtheTrumpadmin-
istration’s “America first” philosophy, cap-
tured in theHHSbudgetoutline, titled “Put-
ting America’s Health First.” Given the cuts
in domestic public health, that title is a
misnomer. It also reflects a stunning failure
to appreciate the interconnected nature of
global health today—where the health of
one nation is linked to the health of all
nations—and the centrality of US health
leadership to both our nation’s values and
global leadership.
The administration’s idea of “America
First” also entails drastic cuts to global
health, including a $2 billion decrease in the
State Department’s global health portfolio
and a $225 million reduction for the Global
Fund to Fight AIDS, Tuberculosis and
Malaria. The Fogarty International Center,
a national treasure for global health capac-
ity building, would be entirely eliminated.
Reproductive health services would
be particularly hard hit, not only by the
proposed cuts, but also by separate
admin i s t ra t ion ac t ion . The Trump
administration
imposed tough
new restrictions
on US support
for aid organi-
z a t i o n s t h a t
provide family
p lanning ser-
vices. And the
Wh i te House
announced eliminating all contributions
to the United Nations Population Fund
(UNFPA), the lead international agency
promoting family planning and child/
maternal health. Overall, the Kaiser Family
Foundation predicts a swift rise in HIV,
abort ions, and maternal and infant
mortal i ty—and a sharp turn toward
isolationism.
If such draconian budget cuts for for-
eign health assistance were implemented,
it would slow progress, costing untold
numbers of lives. Lives in the United States
would be at risk, as infectious diseases
could not be contained at their source.
Cuts in international assistance also
undermine our most potent form of “soft”
diplomacy. The United Statesmakes friends
by investing overseas in health, nutrition,
and education—opening markets to US
companies, advancing trade, and reducing
political and economic instability in fragile
states. In other words, forsaking theworld’s
poor fuels insecurity.
To truly value the idea of “America’s
health first,” thenationneedstospendmore,
not less, on health and biomedicine, both
within our borders and well beyond.
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To truly value the idea of “America’s
health first,” the nation needs to spend
more, not less, on health and
biomedicine, both within our borders
and well beyond.
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